Administration of PPARγ agonists significantly ameliorates insulin sensitivity in mice with high fat diets and patients with T2DM and the improvement of insulin resistance was consistent with the increase in the plasma adiponectin levels [31], [32], and the protective effects of adiponectin has mainly been attributed to its anti-inflammatory action [33]. Here, PPARG is linked to type 2 diabetes mellitus.